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Abstract
 
Engagement of the T cell antigen receptor (TCR) induces the transphosphorylation of the 
 
 
 
chain–associated protein of 70,000 Mr (ZAP-70) protein tyrosine kinase (PTK) by the CD4/8
coreceptor associated Lck PTK. Phosphorylation of Tyr 493 within ZAP-70’s activation loop
results in the enzymatic activation of ZAP-70. Additional tyrosines (Tyrs) within ZAP-70 are
phosphorylated that play both positive and negative regulatory roles in TCR function. Phos-
phorylation of Tyr residues (Tyrs 315 and 319) within the Interdomain B region of the ZAP-70
PTK plays important roles in the generation of second messengers after TCR engagement.
Here, we demonstrate that phosphorylation of these two Tyr residues also play important roles
in mediating the positive and negative selection of T cells in the thymus.
Key words: protein tyrosine kinases • signal transduction • T cell activation • lymphocyte 
development • T cell selection
 
Introduction
 
The antigen receptor repertoire expressed on T cells is de-
pendent on appropriate positive and negative selection of
CD4
 
 
 
CD8
 
 
 
 cells in the thymus (for a review, see refer-
ence 1). These selection processes require the sequential
activation of the antigen receptor–activated protein ty-
 
rosine kinases (PTKs)
 
*
 
-Lck, 
 
 
 
 chain–associated protein of
70,000 Mr (ZAP-70), and IL-2–regulated tyrosine (Tyr)
kinase (for a review, see reference 2). We and others have
previously demonstrated that the TCR-associated ZAP-70
PTK plays essential roles for both positive and negative se-
lection of 
 
  
 
 TCR-bearing thymocytes (3–6). In addition,
ZAP-70 is also required for the generation of multiple sig-
naling intermediates that include calcium and activation of
small G proteins after TCR engagement (7–11). Hence,
the efficient generation of these second messengers is re-
quired for normal thymic selection.
The NH
 
2
 
-terminal tandem src homology (SH)2 domains
of ZAP-70 associate with the dually phosphorylated immu-
noreceptor Tyr-based activation motifs encoded within
each of the TCR signaling polypeptides (see Fig. 1 A; ref-
erences 12–15). The COOH-terminal domain of ZAP-70
encodes its Tyr kinase activity and contains positive and
negative regulatory Tyr residues, Tyrs 493 and 492, respec-
tively, that regulate ZAP-70’s enzymatic activity (16, 17).
Interdomain B bridges the COOH-terminal SH2 and ki-
nase domains and contains three Tyr residues (Tyrs 292,
315, and 319) that are phosphorylated after TCR engage-
ment. Tyr 292 is a binding site for the SH2-like domain of
the cbl protooncogene and serves as a negative regulator of
T cell function (18–23). Phosphorylated Tyr 292 interacts
with cbl, a component of the ubiquitination machinery
(24, 25), and hence may target phospho-Tyr292 ZAP-70
molecules for ubiquitination and degradation. Cells ex-
pressing ZAP-70(Y292F) exhibit a hyperactive phenotype
 
in response to TCR cross-linking with enhanced transcrip-
tional activation of nuclear factor of activated T cell (NF-AT)
and IL-2–regulated promoter elements (19, 20, 23).
In contrast to the negative regulatory Tyr 292, two addi-
tional Tyr residues, Tyrs 315 and 319, play positive regula-
tory roles in TCR signal transduction. Phosphorylated Tyr
315 has been suggested to provide a binding site for the
SH2 domain of the Vav guanine nucleotide exchange fac-
tor, an activator of Rho-GTPases (26, 27). Expression of a
mutant ZAP-70(Y315F) in spleen Tyr kinase (Syk)-defi-
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 chain–associated protein of 70,000 Mr. 
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cient DT40 cells results in attenuated B cell antigen recep-
tor–induced NF-AT–regulated responses (27). However,
expression of ZAP-70(Y315F) in a ZAP-70–deficient Jur-
kat T cell line (P116) has no significant effects on TCR-
activated NF-AT promoter responses (28). Conversely,
expression of ZAP-70(Y319F) in P116 cells results in sig-
nificant attenuation of TCR-induced calcium responses,
Ras activation and NF-AT transcriptional activation (28–
30). In addition, expression of a mutant ZAP-70 in which
the majority of Interdomain B has been deleted, including
Tyrs 292, 315, and 319, results in enhanced B cell antigen
receptor–induced NF-AT responses using the Syk-defi-
cient DT40 cell system, as compared with wild-type (wt)
ZAP-70 (31). Hence, the requirement for these putative
positive regulatory Tyr residues in T cell function is un-
clear. Since ZAP-70 is required for both the positive and
negative selection processes during T cell development and
as generation of second messengers are similarly important
for T cell development, we addressed the roles of these two
Tyr residues in TCR function during T cell development.
 
Materials and Methods
 
Generation of Transgenic Mice.
 
The human ZAP-70 and mu-
tant ZAP-70 cDNAs were appended with a hemagglutinin (HA)
epitope at its NH
 
2
 
 terminus to facilitate protein analysis. The
HA-hZAP-70 cDNA was expressed under the 
 
lck
 
 proximal pro-
moter using the p1017 vector (32). Injection of hZAP-70 trans-
genes (Tg) into C57BL/6 oocytes and implantation into
pseudopregnant recipient mice were performed as described pre-
viously (33). Founder mice were screened for Tg expression us-
ing a probe encoding the 3
 
 
 
-human growth hormone gene (33).
Tg
 
 
 
 mice were crossed with 
 
zap-70
 
 
 
/
 
 
 
 mice to generate
Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 mice, which in turn were backcrossed with 
 
zap-
70
 
 
 
/
 
 
 
 mice to generate Tg
 
 
 
zap-70
 
 
 
/
 
  
 
and Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 mice.
All mice examined were hemizygous for the ZAP-70 Tg. Geno-
typing for 
 
zap-70
 
 was performed using PCR primers as described
previously (3). The 
 
zap-70
 
 
 
/
 
 
 
 mice have been maintained on a
C57BL/6 background for 
 
 
 
20 generations and the Tg
 
 
 
 mice
were maintained on a C57BL/6 background.
H-Y TCR
 
 
 
/H-Y TCR
 
 
 
 
 
zap-70
 
 
 
/
 
 
 
 mice were generated by
crossing H-Y TCR
 
 
 
/H-Y TCR
 
 
 
 mice with 
 
zap-70
 
 
 
/
 
 
 
 mice
and intercrossing H-Y TCR
 
 
 
 zap-70
 
 
 
/
 
  
 
mice to generate H-Y
TCR
 
 
 
/H-Y TCR
 
 
 
 
 
zap-70
 
 
 
/
 
 
 
 mice (3, 34). These mice were
then bred with Tg
 
 
 
zap-70
 
 
 
/
 
  
 
mice to generate H-Y TCR
 
 
 
Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 and H-Y TCR
 
 
 
Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 for analysis. All
mice were analyzed within an age range of 4–6 wk.
 
Antibodies, Cell Analysis, and Protein Analysis.
 
Antibodies
used for protein analysis in this study include: 12CA5, an anti-
HA epitope mAb (Babco), anti-phospholipase C 
 
  
 
(PLC
 
 
 
)1
raised against a fusion protein encoding both SH2 and the SH3
domains, anti-linker of activated T cell (LAT) antisera (Upstate
Biotechnology), 4G10, an antiphophotyrosine mAb (Upstate
Biotechnology), anti-pErk and Erk antisera (New England Bio-
labs, Inc. and Santa Cruz Biotechnology, Inc., respectively), anti–
ZAP-70 antiserum (19), and an anti-Syk mAb (Upstate Biotech-
nology). Antibodies used for FACS
 
®
 
 analysis were purchased
from BD PharMingen. The anti-HY mAb was a gift of Dr. H.S.
Teh (University of British Columbia, Vancouver, Canada).
For protein analysis, cells were lysed at 2 
 
 
 
 10
 
8
 
 cells per milli-
liter in 10 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40 and pro-
 
tease and phosphatase inhibitors as described previously (lysis
buffer) (19). Lysates were clarified by centrifugation at 14,000
 
 
 
 
 
g
 
for 10 min at 4
 
 
 
C. Cell lysates were incubated with the appropri-
ate antiserum for 2 h at 4
 
 
 
C, immunoprecipitated with protein
A-Sepharose (Pierce Chemical Co.) for 1 h at 4
 
 
 
C, washed three
times with lysis buffer, and proteins resolved by SDS-PAGE.
Western blot analysis was performed using enhanced chemilumi-
nescence (Amersham Pharmacia Biotech) according to the manu-
facturer’s recommendations. Quantitation of band intensity was
performed using UN-SCAN-IT software.
Analysis of cell surface markers was performed using FACS-
Calibur™ (Becton Dickinson) and analyzed using CELLQuest™
software (Becton Dickinson).
 
T Cell Activation.
 
For analysis of free cytoplasmic calcium
([Ca
 
2
 
 
 
]
 
i
 
) mobilization after TCR cross-linking, cells were incu-
bated with the calcium-sensitive dye, Fura-2 (Molecular Probes),
and analyzed by spectrofluorimetry using a FT2000 fluorimeter.
In brief, cells were incubated at 37
 
 
 
C with a biotinylated anti-
CD3
 
 
 
 mAb (2C11, 10 
 
 
 
g/ml) and cross-linked with 2.5 
 
 
 
g/ml
avidin. Loading of cells was monitored by the ability of cells to
increase [Ca
 
2
 
 
 
]
 
i
 
 in response to ionomycin. The maxima and
minima to determine absolute calcium concentrations were ob-
tained by lysing cells with Triton X-100 and quenching with
EDTA, respectively.
For biochemical studies, thymocytes were suspended in com-
plete media (2 
 
  
 
10
 
8
 
 cells per milliliter) and rested for 15 min at
37
 
 
 
C. Anti-CD3
 
 
 
 mAb (2C11, 10 
 
 
 
g/ml) was added to cells and
incubated for the appropriate stimulation time before cell lysis as
described above.
 
Results
 
Generation of ZAP-70(Y315F) and ZAP-70(Y319F) Tg
Mouse Lines.
 
Tg encoding either ZAP-70(Y315F) or
ZAP-70(Y319F) were expressed in the thymus under the
control of the 
 
lck
 
 proximal promoter (Fig. 1 A; reference
32). Four independent transgenic lines were established for
each mutant molecule. Based on the levels of protein ex-
pression, two lines for each mutant ZAP-70 molecule were
selected for further study. To ensure that expression of
ZAP-70 under a heterologous promoter did not alter T cell
development, Tg mice expressing wt ZAP-70 were also
generated under the control of the 
 
lck
 
 proximal promoter
and bred with 
 
zap-70
 
 
 
/
 
 
 
 mice for two generations. The
Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 mice were then compared with 
 
zap-70
 
 
 
/
 
 
 
and 
 
zap-70
 
 
 
/
 
 
 
 mice. All exogenous ZAP-70 molecules
were linked to an epitope tag at their NH
 
2
 
 termini to facil-
itate analysis of protein expression levels. Studies in Jurkat
T cells have demonstrated that this epitope tag does not in-
terfere with ZAP-70 function (data not shown).
Immunoblot analysis of total thymocytes demonstrated
comparable levels of exogenous ZAP-70 were expressed
amongst the transgenic lines with the exception of line 974
which expressed the mutant ZAP-70(Y319F) at approxi-
mately fourfold higher levels of ZAP-70 as compared with
the other Tgs (Fig. 1 B). In the remaining three transgenic
lines, the exogenous ZAP-70 molecules were expressed at
levels comparable to 
 
zap-70
 
 
 
/
 
 
 
 thymocytes (Fig. 1 C and
data not shown). Consistent with the decreased transcrip-
tional activity of the 
 
lck
 
 proximal promoter in peripheral as 
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compared with immature T cells (32), the expression of
the Tg ZAP-70 proteins was decreased in the periphery.
This prohibited a valid comparison of peripheral T cell
function in Tg
 
 
 
zap-70
 
 
 
/
 
 
 
 mice with 
 
zap-70
 
 
 
/  mice (data
not shown).
T Cell Development of zap-70 /  Mice with Enforced Ex-
pression of wt ZAP-70 under the Control of the Lck Proximal
Promoter Is Comparable to zap-70 /  Mice. To ensure that
expression of ZAP-70 under the control of the lck proximal
promoter did not affect the function of ZAP-70 in T cell
development, we first compared the phenotype of Tg(wt
ZAP-70)  zap-70 /  mice with zap-70 /  mice. While
zap-70 /  mice accumulate CD4 CD8  thymocytes (3),
expression of either the wt ZAP-70 Tg or endogenous
ZAP-70 restored the development of CD4  and CD8 
thymocytes (Fig. 2 A). Total thymocyte number and sub-
sets (CD4 CD8 , CD4 CD8 , CD4  and CD8  stages)
were comparable in Tg(wt ZAP-70)  zap-70 /  and zap-
70 /  mice (Fig. 2 A and Table I). The percentage of
CD3  T cells and the mean fluorescence intensity (MFI)
for CD3 were comparable between the two groups. Similar
profiles of CD4  and CD8  T cells were also observed in
the spleen and lymph node (Fig. 2 B and data not shown).
To permit analysis of mutant ZAP-70 molecules during
T cell development, we generated Tg(wt ZAP-70)  zap-
70 /  or zap-70 /  mice expressing an H-Y transgenic
TCR specific for H-Y male antigen under the H-2b select-
ing background (35). Positive selection of H-Y TCR 
T cells, as determined by the numbers of H-Y
TCR CD4 CD8  and CD8  T cells in female mice was
comparable between Tg(wt ZAP-70)  zap-70 /  and zap-
70 /  mice (Fig. 3 A and Table II). The MFI of CD8 and
CD3 was also similar between the two groups (Fig. 3 A and
data not shown). Hence, positive selection of T cells was
not affected by the enforced expression of wt ZAP-70 as
compared with endogenous ZAP-70.
Surprisingly, while zap-70 /  mice without a Tg TCR
accumulate CD4 CD8  T cells (3), the expression of the
H-Y TCR in zap-70 /  thymocytes induced an earlier
block at the CD4 CD8  stage and decreased development
of H-Y TCR CD4 CD8  thymocytes (Fig. 3 A). This
earlier block was not unique to the H-Y TCR since zap-
70 /  mice expressing the DO11.10 TCR also accumu-
lated a greater percentage of CD4 CD8  thymocytes
(data not shown). As expression of Syk was not altered in
the Tg(wt ZAP-70) zap-70 /  mice as compared with
zap-70 /  mice (data not shown), these differences likely
reflect the earlier enforced expression of the TCR Tg and
Figure 1. Generation and
analysis of transgenic mice. (A)
Schematic representation of Tgs
used. The schematic structure of
ZAP-70 is shown at the top.
The Tyr residues that are phos-
phorylated after TCR engage-
ment are depicted. The positive
regulatory Tyr residues are listed
above the ZAP-70 structure
while the negative regulatory
Tyr residues are listed below the
structure. The three Tgs (wt
ZAP-70, ZAP-70[Y315F], and
ZAP-70[Y319F]) regulated by
the  lck proximal promoter and
stabilized by the human growth
hormone polyA tail are depicted
below the ZAP-70 schematic
structure. Each of the Tgs was
appended with a HA epitope tag
at their NH2 terminus. (B) Ex-
pression of the ZAP-70 Tgs.
Cell lysates isolated from 107
thymocytes were analyzed by
immunoblotting with an anti-
HA mAb (top) or an anti-Cbl
antiserum (bottom). Two inde-
pendent lines were derived for
each of the mutant ZAP-70
molecules. (C) Expression of wt
ZAP-70 Tg is comparable to
zap-70 /  thymocytes. Cell ly-
sates isolated from two represen-
tative wt ZAP-70 zap-70 / 
(lanes 1 and 2), wt ZAP-70 zap-
70 /  (lane 3), and zap-70 / 
(lane 4) thymocytes were ana-
lyzed by immunoblotting with
an anti–ZAP-70 antiserum.510 ZAP-70 in T Cell Development
hence, signaling differences in pre- and    TCRs (see
Discussion).
Finally, we examined the ability of the Tg(wt ZAP-70)
to mediate the deletion of H-Y TCR  T cells in male
mice. Consistent with the requirement for ZAP-70 in
negative selection, H-Y TCR   zap-70 /  male mice
demonstrated increased thymocyte number and accumu-
lated H-Y TCR CD4 CD8  thymocytes (Table II and
Fig. 3 B). However, no H-Y TCR CD8  T cells were
observed in the thymus or periphery. Reconstitution of
zap-70 /  mice with the Tg(wt ZAP-70) restored the
ability of the H-Y TCR  T cells to undergo negative se-
Figure 2. Expression of wt ZAP-70
under the control of the lck proximal
promoter restores T cell develop-
ment in zap-70 /  mice. Thy-
mocytes (A) and splenocytes (B) from
zap-70 / , wt ZAP-70 zap-70 / ,
or zap-70 /  mice were analyzed by
FACS® for the expression of CD4
and CD8 (top) or CD3 (bottom).
The percentage of cells detected in
each quadrant is listed within each
quadrant or above each gate. Total
cell number isolated from each geno-
type is represented in Table I.
Table I. Cell Number and Subset Distribution of Thymocytes
Percentage of cells within T cell subset
Genotype
Number of mice
analyzed Cell number CD4 CD8  CD4 CD8  CD4 CD8  CD4 CD8 
n   10 6
Tg zap-70 /  35 330   19a 4.3   0.3 81.2   2.2 8.6   0.4 3.6   0.2
wt ZAP-70 zap-70 /  10 311   56 4.4   0.5 80.8   1.1 10.5   0.5 4.2   0.5
ZAP-70(Y319F) zap-70 /  (line 985) 10 263   16 6.0   0.5 87.6  0.5 3.1   0.2b 3.0   0.2
ZAP-70(Y319F) zap-70 /  (line 974) 8 266   40 5.2   0.5 85.9   0.8 5.7   0.8b 3.2   0.2
ZAP-70(Y315F) zap-70 /  (line 1059) 17 265   34 3.7   0.7 83.0   0.9 8.6   0.4 4.4   0.3
ZAP-70(Y315F) zap-70 /  (line 1075) 9 348   45 3.7   0.3 86.0  1.3 7.4   0.8 3.1   0.4
a  SEM.
bP   0.001.511 Gong et al.
lection. H-Y TCR  T cells in zap-70 /  male mice were
deleted to a comparable extent as that observed in Tg(wt
ZAP-70)  zap-70 /  male mice (Fig. 3 B and Table II).
Hence, transgenic expression of wt ZAP-70 in zap-70 / 
mice does not compromise either positive or negative se-
lection processes.
Analysis of Thymocyte Development in Mice Expressing
ZAP-70(Y315F) or ZAP-70(Y319F). Since  zap-70 / 
mice expressing Tg(wt ZAP-70) under the lck proximal
promoter reconstituted the ability of cells to undergo posi-
tive and negative selection, we next analyzed the ability of
mutant ZAP-70 molecules that cannot be phosphorylated
on Tyrs 315 or 319 to reconstitute T cell development in
zap-70 /  mice. Using a similar strategy as that employed
for Tg(wt ZAP-70), we analyzed two independent lines for
mice expressing ZAP-70(Y319F) (lines 985 and 974) or
ZAP-70(Y315F) (lines 1059 and 1075). Thymocytes
harvested from zap-70 /  mice expressing the ZAP-
70(Y319F) Tg demonstrated an  50% decrease in CD4 
T cells (Fig. 4 A and Table I). A small decrease in CD8  T
cells was observed, though the difference was not statisti-
cally significant. However, a decrease in both CD4  and
Figure 3. Expression of wt
ZAP-70 regulated by the lck
proximal promoter reconstitutes
both positive and negative selec-
tion of H-Y TCR  thymocytes.
(A) H-Y TCR  thymocytes
(top) and splenocytes (bottom)
from  zap-70 / , wt ZAP-
70 zap-70 / , or zap-70 / 
H-Y TCR  female mice were
analyzed for CD4 and CD8 ex-
pression by FACS® analysis. The
number of thymocytes isolated
from each mouse is depicted
above each analysis. Thymocytes
shown represent the H-Y
TCR  population as defined by
T3.70 staining. Average thy-
mocyte number isolated for each
genotype is represented in Table
II. (B) H-Y TCR  thymocytes
(top) and splenocytes (bottom)
from  zap-70 / , wt ZAP-
70 zap-70 / , or zap-70 /  H-Y
TCR  male mice were analyzed
by FACS® analysis as described
above. Thymocytes shown rep-
resent the H-Y TCR  popula-
tion as defined by T3.70 stain-
ing. Average thymocyte number
isolated for each genotype is rep-
resented in Table II.
Table II. Cell Number from H-Y TCR  Female and Male Mice
H-Y TCR  Female H-Y TCR  Male
Genotype Cell number Number of mice analyzed Cell number Number of mice analyzed
  10 6 n   10 6 n
Tg zap-70 /  185   27a 8 27.6   3.5 3
Tg zap-70 /  167   11 13 28.2   2.6 14
Tg zap-70 /  88   10b 7 104   16b 5
wt ZAP-70 zap-70 /  137   6 3 27.7   6.2 3
ZAP-70(Y319F) zap-70 /   213   22 11 202  37b 6
ZAP-70(Y315F) zap-70 /   121   11b 7 116   17b 3
a  SEM.
bP   0.001, compared with zap-70  /  mice.512 ZAP-70 in T Cell Development
CD8  T cells was observed in the periphery of mice ex-
pressing ZAP-70(Y319F) (Fig. 4 B). Hence, mice express-
ing ZAP-70(Y319F) demonstrate compromised develop-
ment of mature single positive T cells as compared with
zap-70 /  or Tg(wt ZAP-70) zap-70 /  mice. The differ-
ences in the level of ZAP-70(Y319F) expression amongst
the two transgenic lines did not affect the extent of the T
cell developmental defect. Hence, the fourfold overexpres-
sion of ZAP-70(Y319F) observed in line 974 did not res-
cue this developmental defect.
In contrast to the developmental abnormalities observed
in mice expressing the ZAP-70(Y319F) Tg, mice express-
ing the ZAP-70(Y315F) Tg demonstrated comparable T
cell numbers and T cell subsets as zap-70 /  mice (Fig. 5 A
and Table I). The percentage of CD3  T cells and the MFI
for CD3 expression were comparable between ZAP-
70(Y315F) zap-70 / , wt ZAP-70 zap-70 / , and zap-
70 /  mice. These cells were similarly able to populate pe-
ripheral lymphoid organs as comparable numbers of CD4 
and CD8  T cells were detected in the spleen and lymph
node (Fig. 5 B and data not shown).
Analysis of Mice Expressing Transgenic TCRs and Mutant
ZAP-70 Molecules. We then analyzed the effects of the
two Tyr residues in mice expressing the H-Y transgenic
TCR. While ZAP-70(Y319F) zap-70 /  mice demon-
strated a moderate compromise in the development of
CD4  T cells as compared with zap-70 /  mice (Fig. 4),
mice expressing ZAP-70(Y319F) when bred upon the
H-Y TCR background demonstrated a more substantial
block. The development of CD8  H-Y TCR  thy-
mocytes was compromised in ZAP-70(Y319F) zap-70 / 
female mice bearing the H-Y TCR (Fig. 6 A). This de-
crease did not reflect increased emigration of cells from the
thymus into the periphery since the peripheral T cell com-
partment was also devoid of these H-Y TCR  T cells (Fig.
6 A, bottom, and data not shown). Similar data were ob-
tained for both transgenic lines expressing ZAP-70(Y319F)
(data not shown). Hence, Tyr 319 is critical in the positive
selection of the H-Y TCR –bearing thymocytes.
While zap-70 /  mice expressing the ZAP-70(Y315F)
Tg did not demonstrate any significant developmental de-
fects on a non-TCR transgenic background, these mice
Figure 4. Attenuated development of T cells in zap-70 /  mice expressing ZAP-70(Y319F). Thymocytes (A) and splenocytes (B) isolated from
ZAP-70(Y319F) zap-70 /  mice were analyzed for CD4 and CD8 (top) and CD3 (bottom) expression. Representative profiles of two independent
transgenic lines (985 and 974) are shown. Average thymocyte number isolated for each genotype is represented in Table I.513 Gong et al.
exhibited a significant block in development when bred
upon the H-Y TCR background. Development of CD8 
H-Y TCR  thymocytes was compromised in ZAP-
70(Y315F) zap-70 /  female mice bearing the H-Y
TCR (Fig. 6 B). The decrease in CD8  H-Y TCR  thy-
mocytes was not due to increased emigration to the pe-
riphery as there was a paucity of CD8  H-Y TCR  T
cells found in the spleen or lymph node (Fig. 6 B and data
not shown). Similar data were obtained for both trans-
genic lines expressing ZAP-70(Y315F) (data not shown).
Hence, Tyr 315 also appears critical for the positive selec-
tion of H-Y TCR  thymocytes, though the degree of
compromise appeared less severe than the H-Y TCR 
ZAP-70(Y319F) zap-70 /  female mice. This lesser de-
velopmental block may reflect the more mild signaling de-
fects observed in the ZAP-70(Y315F) zap-70 /  mice
(see below).
Requirement for Tyrs 315 and 319 in Negative Selection.
Analysis of H-Y TCR  male mice expressing either Y315F
or Y319F mutants permitted us to further assess the re-
quirements of these two Tyr residues in the elimination of
T cells engaging self-antigen. While H-Y TCR  zap-70 / 
and wt ZAP-70 zap-70 /  male mice demonstrated de-
letion of H-Y TCR  thymocytes (Fig. 3 and Table II),
H-Y TCR  male mice expressing ZAP-70(Y319F) accumu-
lated approximately sixfold greater numbers of thymocytes
(Table II). These mutant male mice had a greater percent-
age and number of H-Y TCR  CD4 CD8  thymocytes
as well as H-Y TCR  CD8  peripheral T cells as com-
pared with zap-70 /  male mice (Fig. 7 A). In addition,
the CD8 MFI in the ZAP-70(Y319F) zap-70 /  male
mice was higher than the zap-70 /  male controls. Analysis
of the H-Y TCR  ZAP-70(Y315F) zap-70 /  male mice
also demonstrated a requirement for Tyr 315 in negative
selection. H-Y TCR  male mice expressing ZAP-
70(Y315F) accumulated approximately fourfold greater
numbers of thymocytes as compared with H-Y TCR 
zap-70 /  male mice (Table II). These mutant mice also
expressed a greater percentage and number of both H-Y
TCR  CD4 CD8  T cells as compared with zap-70 / 
mice (Fig. 7 B). Interestingly, there was significantly less
development of H-Y TCR CD4 CD8  thymocytes in
male mice expressing ZAP-70(Y315F)  as compared with
ZAP-70(Y319F) zap-70 /  mice. Hence, the degree of
compromise observed for ZAP-70(Y319F) was again more
profound than for ZAP-70(Y315F). The CD8 MFI of
Figure 5. Normal development of T cells in zap-70 /  mice expressing ZAP-70(Y315F). Thymocytes (A) and splenocytes (B) isolated from
ZAP-70(Y315F) zap-70 /  mice were analyzed for CD4 and CD8 (top) and CD3 (bottom) expression. Representative profiles of two independent
transgenic lines (1059 and 1075) are shown. Average thymocyte number isolated for each genotype is represented in Table I.514 ZAP-70 in T Cell Development
these ZAP-70(Y315F) zap-70 /  cells was also higher
than the H-Y TCR  CD8  zap-70 /  male mice though
the difference was less marked as those found in mice ex-
pressing ZAP-70(Y319F). Together, these data indicate
that both Tyrs 315 and 319 are important for both positive
and negative selection of H-Y TCR  thymocytes.
Defects in [Ca2 ]i Signaling in ZAP-70(Y315F) and ZAP-
70(Y319F) Thymocytes. Since ZAP-70 is required for the
Figure 6. Attenuated positive selection of H-Y TCR  T cells in zap-70 /  mice expressing ZAP-70(Y319F) or ZAP-70(Y315F). H-Y TCR  thymi
(top) or lymph nodes (bottom) from ZAP-70(Y319F) zap-70 /  (A) or ZAP-70(Y315F) zap-70 /  (B) female mice were analyzed for CD4 and CD8
expression. Cells shown represent the H-Y TCR  population as defined by T3.70 staining. Average thymocyte number isolated for each genotype is
represented in Table II.
Figure 7. Attenuated negative selection of H-Y
TCR  T cells in zap-70 /  mice expressing ZAP-
70(Y319F) or ZAP-70(Y315F). (A) H-Y TCR  thymi
(top), splenocytes (center), or lymph nodes (bottom)
were analyzed for CD4 and CD8 expression. A repre-
sentative FACS® profile from an H-Y TCR zap-70 / 
male mouse (left) and ZAP-70(Y319F) zap-70 / 
male mouse (second from left) is shown. A representa-
tive profile of an H-Y TCR zap-70 /  female mouse
(third from left) is also depicted for comparison. Cells
shown represent the H-Y TCR  population as defined
by T3.70 staining. A histogram for CD8 expression of
H-Y TCR  thymocytes is shown on the right. The
dotted line denotes the H-Y TCR zap-70 /  male
mouse while the solid line denotes the H-Y
TCR ZAP-70(Y319F) zap-70 /  mouse. Quantita-
tion of the MFI of the right peak for each mouse is de-
picted above the peak. (B) H-Y TCR  thymi (top),
splenocytes (center), or lymph nodes (bottom) were an-
alyzed for CD4 and CD8 expression as described above.
The mode of presentation is the same as in A except the
Tg represents the ZAP-70(Y315F) mutant molecule.515 Gong et al.
increases in [Ca2 ]i after TCR cross-linking, we analyzed
the TCR induced increase in [Ca2 ] i in thymocytes iso-
lated from zap-70 / , Tg(wt ZAP-70)  zap-70 / , ZAP-
70(Y319F) zap-70 / , or ZAP-70(Y315F) zap-70 / 
mice. While thymocytes isolated from zap-70 /  or Tg
(wt ZAP-70) zap-70 /  mice demonstrated comparable
increases in [Ca2 ]i, thymocytes isolated from ZAP-
70(Y319F) zap-70 /  mice demonstrated a significant at-
tenuation in TCR-induced increase in [Ca2 ]i (Fig. 8 A).
The attenuation in [Ca2 ]i mobilization was observed not
only in the total thymocyte population, but also in puri-
fied CD4 CD8  and CD4  thymocytes (Figs. 8, B and
C). In contrast, thymocytes isolated from mice expressing
ZAP-70(Y315F) zap-70 /  demonstrated a small, but
reproducible, attenuation in TCR-induced increase in
[Ca2 ] i (Fig. 8 A). This difference was not observed in the
less responsive CD4 CD8  thymocytes, but was more ac-
centuated in the CD4  thymocyte population (Fig. 8, B
and C). Consistent with the requirement for PLC  activa-
tion in Erk activation (36, 37), Erk activation was slightly
attenuated (25% reduction) in both zap-70 /  thymocytes
expressing either ZAP-70(Y315F) or ZAP-70(Y319F)
(Fig. 8 D). Hence, phosphorylation of Tyrs 315 and 319
contribute to the generation of second messengers after
TCR cross-linking.
Discussion
The ZAP-70 PTK has been demonstrated to be required
for the positive and negative selection of thymocytes as
well as for the efficient activation of multiple signaling
pathways in T cells (3, 4, 6). In this study, we generated
zap-70 /  mice expressing mutant ZAP-70(Y315F) or
ZAP-70(Y319F) Tg that permitted us to examine the roles
of two Interdomain B containing–Tyr residues in mediat-
ing T cell development. ZAP-70(Y319F) zap-70 /  mice
demonstrated compromised development of CD4  thy-
mocytes and CD4  and CD8  T cells in peripheral lym-
phoid organs (Fig. 4 and Table I). In contrast, no significant
defects were observed in zap-70 /  mice expressing the
ZAP-70(Y315F) Tg (Fig. 5 and Table I). While the levels
of protein expression achieved in the transgenic lines were
selected to closely resemble the endogenous level, we
cannot exclude potential positional effects of the Tgs.
However, two independent lines of each mutant ZAP-70
molecule provided similar results and the analysis of the
ZAP-70(Y315F) zap-70 /  mice is similar to the pheno-
type generated using a knockin approach (38). Moreover,
the developmental defect observed in ZAP-70(Y319F) 
zap-70 /  mice was not restored even with fourfold over-
expression of the ZAP-70(Y319F) mutant protein as
achieved in the transgenic line 974. Together, these data
indicate a hierarchy in the requirements for these Tyr resi-
dues in mediating T cell development.
While T cells developed in the absence of either Tyr 315
or 319, the affinities of the receptors in T cells of mice ex-
pressing ZAP-70(Y315F) or ZAP-70(Y319F) may be al-
tered to compensate for potential signaling deficiencies ac-
tivated by these mutant ZAP-70 molecules. To address this
possibility, we analyzed further the roles of these two Tyr
residues with a fixed affinity transgenic TCR. Using the
H-Y TCR transgenic system, we analyzed H-Y TCR 
zap-70 /  mice and H-Y TCR zap-70 /  mice encoding
the two mutant ZAP-70 molecules.
Surprisingly, while zap-70 /  mice develop and accu-
mulate TCRloCD4 CD8  thymocytes, the enforced ex-
pression of the H-Y TCR substantially compromised the
Figure 8. Signaling defects in ZAP-70(Y319F) zap-70 /  and ZAP-
70(Y315F) zap-70 /  thymocytes. Increases in [Ca2 ]i after TCR
engagement from zap-70 / , (wt ZAP-70) zap-70 / , ZAP-
70(Y315F) zap-70 / , or ZAP-70(Y319F) zap-70 /  T cells were mea-
sured as described in Materials and Methods. The arrows denote the addi-
tions of biotinylated anti-CD3  mAb followed by cross-linking with
avidin. Increases in [Ca2 ]i were measured for total thymocytes (A), puri-
fied CD4 CD8  thymocytes (B) as well as for CD4  thymocytes (C).
(D) Erk activation was measured by immunoblot analysis of cell lysates
using an anti-pErk antibody (top). Equal loading of cell lysates was moni-
tored by immunoblotting with an anti-total Erk antibody (bottom).
These measurements were representative of a minimum of three indepen-
dent experiments. Similar results were obtained independent of the
method for isolation of the thymocyte subsets.516 ZAP-70 in T Cell Development
development of the H-Y TCR  CD4 CD8  population
in female mice (Fig. 3 A). This earlier developmental block
was not unique to the H-Y TCR transgenic system as a
similar block was also observed in zap-70 /  mice bearing
the DO11.10 TCR specific for OVA (data not shown).
While CD4 CD8  thymocytes can utilize either ZAP-70
or Syk in mediating the function of the    TCR (6, 39),
the earlier expression of an H-Y    TCR Tg likely results
in an earlier downregulation of the Syk PTK and hence a
greater dependence on ZAP-70 (40). As expression of the
H-Y     TCR results in accelerated development of
CD25 CD44 CD4 CD8  thymocytes (DN4 stage) with
a paucity of CD25 CD44 CD4 CD8  thymocytes (DN3
stage), we were unable to determine whether the H-Y
TCR induces an earlier decrease in the level of Syk expres-
sion at the DN3 to DN4 transition (data not shown).
However, consistent with the idea that the accelerated ex-
pression of the H-Y TCR is more dependent on ZAP-70,
H-Y TCR–bearing thymocytes expressing a Syk Tg are
unable to mature into CD4 CD8  thymocytes (unpub-
lished data). These data implicate potential signaling differ-
ences in the ZAP-70 and Syk kinases in shaping the antigen
receptor repertoire, and may account for the earlier block
in thymocyte development observed in H-Y TCR zap-
70 /  female mice.
Consistent with the requirement for ZAP-70 in the in
vitro deletion of DO11.10 TCR zap-70 /  thymocytes
(3), H-Y TCR zap-70 /  male mice demonstrate compro-
mised negative selection of H-Y TCR  thymocytes (Fig. 3
B and Table II). H-Y TCR zap-70 /  male mice also
demonstrate a threefold increase in total thymocyte num-
ber and accumulate H-Y TCR CD4 CD8  thymocytes.
However, these cells do not mature further to CD8  thy-
mocytes or peripheral T cells.
Using this H-Y TCR zap-70 /  transgenic system,
analysis of mice expressing either mutant ZAP-70 molecule
revealed a range of developmental defects. While non-
TCR transgenic mice demonstrate a twofold decrease in
the development of CD4  thymocytes and in peripheral T
cells, H-Y TCR ZAP-70(Y319F) zap-70 /  female mice
exhibit a more substantial block that was qualitatively
similar to the developmental block observed in H-Y
TCR zap-70 /  mice (Figs. 3 A and 6 A). Conversely,
non-TCR Tg ZAP-70(Y315F) zap-70 /  mice demon-
strate no significant thymic developmental defects. How-
ever, H-Y TCR ZAP-70(Y315F) zap-70 /  female mice
demonstrate compromised development of H-Y TCR 
CD8  thymocytes and, correspondingly, do not develop
H-Y TCR CD8  peripheral T cells (Fig. 6).
Similar to the range of defects in the positive selection of
H-Y TCR  T cells observed in H-Y TCR  female mice,
these differences are paralleled in their H-Y TCR  male
counterparts. H-Y TCR  zap-70 /  mice expressing ei-
ther ZAP-70(Y319F) or ZAP-70(Y315F) Tgs accumulate
six and fourfold, respectively, greater thymocyte number as
compared with H-Y TCR  zap-70 /- or H-Y TCR  wt
ZAP-70 zap-70 /  male mice (Table II). In addition, the
MFIs for CD4 and CD8 expression follow a hierarchy that
paralleled the efficiency of selection in the male mice:
ZAP-70(Y319F) zap-70 /     ZAP-70(Y315F) zap-
70 /    zap-70 /  thymocytes. These differences further
support the notion that the ZAP-70(Y319F) zap-70 / 
and to a lesser degree ZAP-70(Y315F) zap-70 /  thy-
mocytes are unable to undergo efficient deletion.
Finally, the biochemical defects observed in the ZAP-
70(Y319F)-expressing thymocytes is consistent with the
analysis of Jurkat T cells expressing ZAP-70(Y319F).
While TCR activation appears to be unaltered, Tyr phos-
phorylation of PLC 1 and LAT is attenuated (28). In turn,
these thymocytes demonstrate defects in [Ca2 ]i mobiliza-
tion and Erk activation (Fig. 8). Additionally, the ability of
these thymocytes to upregulate CD69 in vitro in response
to anti-CD3  cross-linking was also compromised (data not
shown). Hence, phosphorylated 319 through its potential
interactions with Lck and PLC 1 may contribute to the as-
sembly and stability of macromolecular signaling complexes
required for efficient and sustained generation of second
messengers (29, 30, 28).
Minimal biochemical defects were observed in ZAP-
70(Y315F) zap-70 /  thymocytes. Tyr phosphorylation
of cellular proteins, including PLC 1, LAT, SH2 domain–
containing leukocyte protein of 76,000 Mr, and Vav, in
ZAP-70(Y315F) zap-70 /  thymocytes was minimally
decreased as compared with zap-70 /  thymocytes (data
not shown). One functional defect observed in these thy-
mocytes was a slight, but reproducible, decrease in [Ca2 ]i
in total thymocytes with a slightly more substantial de-
crease in CD4 CD8  thymocytes. This defect is reminis-
cent of the signaling differences observed in fyn /  mice
in which CD4  thymocytes demonstrated greater [Ca2 ]i
signaling defects as compared with CD4 CD8  thy-
mocytes (41). In addition, a slight attenuation in TCR-
induced Erk activation was observed in ZAP-
70(Y315F) zap-70 /  thymocytes. Differences in the
stability of the ZAP-70(Y315F)–TCR complex have been
observed (reference 38 and data not shown). This com-
promised stability of ZAP-70(Y315F)–TCR complexes
and, hence, decreased longevity of the activated ZAP-70
kinase may provide a biochemical basis for these func-
tional and developmental abnormalities.
While the biochemical defects observed in ZAP-
70(Y315F) zap-70 /  and ZAP-70(Y319F) zap-70 /  thy-
mocytes are mild to moderate and while only a moderate
degree of compromise in T cell development was observed
in ZAP-70(Y319F) zap-70 /  mice, the expression of a
Tg TCR resulted in severe compromise in both the posi-
tive and negative selection of H-Y TCR  thymocytes.
While it is possible that these alterations may be unique to
the H-Y TCR Tg system, it is more likely that the en-
forced expression of a low affinity TCR magnifies more
subtle and prolonged signaling defects that would other-
wise be compromised by alterations receptor affinity or
repertoire. As the affinity of the H-Y TCR for H-Y anti-
gen is still higher than for a non-Tg TCR for its cognate
ligand, it is likely that mutations in these two Interdomain
B Tyr residues may result in attenuated signaling and shift517 Gong et al.
the repertoire of receptors such that self-reactive antigen
receptors may not be efficiently eliminated and contribute
to autoimmunity.
The authors thank Dr. H.S Teh (University of British Columbia)
for the gift of the anticlonotypic H-Y TCR mAb, Dr. R. Perlmut-
ter for the p1017 vector, and Drs. Bernard and Marie Malissen for
communicating their unpublished data.
A grant from the National Institutes of Health (NIH, CA74881)
provided partial support for this work. A.C. Chan is an Associate
Investigator of the Howard Hughes Medical Institute. J.B. War-
denburg is supported by the NIH (5T32GM07200).
Submitted: 3 April 2001
Revised: 11 May 2001
Accepted: 17 May 2001
References
1. Goldrath, A., and M. Bevan. 1999. Selecting and maintaining
a diverse T-cell repertoire. Nature. 402:255–262.
2. Cheng, A.M., and A.C. Chan. 1997. Protein tyrosine kinases
in thymocyte development. Curr. Opin. Immunol. 8:394–401.
3. Negishi, I., N. Motoyama, K.-I. Nakayama, K. Nakayama, S.
Senju, S. Hatakeyama, Q. Zhang, A.C. Chan, and D.Y. Loh.
1995. Essential role for ZAP-70 in both positive and negative
selection of thymocytes. Nature. 376:435–438.
4. Wiest, D.L., J.M. Ashe, K. Howcraft, H.-M. Lee, D.M.
Kemper, I. Negishi, A. Singer, and R. Abe. 1997. A sponta-
neously arising mutation in the DLAARN motif of murine
ZAP-70 abrogates kinase activity and arrests thymocyte de-
velopment. Immunity. 6:663–671.
5. Kadlecek, T., N. van Oers, L. Lefrancois, S. Olson, D. Fin-
lay, D. Chu, K. Connolly, N. Killeen, and A. Weiss. 1998.
Differential requirements for ZAP-70 in TCR signaling and
T cell development. J. Immunol. 161:4688–4694.
6. Sugawara, T., V. DiBartolo, T. Miyazaki, H. Nakauchi, O.
Acuto, and Y. Takahama. 1998. An improved retroviral gene
transfer technique demonstrates inhibition of CD4 CD8 
thymocyte development by kinase-inactive ZAP-70. J. Im-
munol. 161:2888–2894.
7. Arpaia, E., M. Shahar, H. Dadi, A. Cohen, and C. Roifman.
1994. Defective T cell receptor signaling and CD8  thymic
selection in humans lacking ZAP-70 kinase. Cell. 76:947–
958.
8. Chan, A., T. Kadlecek, M. Elder, A. Filipovich, J. Grey, M.
Iwashima, T. Parslow, and A. Weiss. 1994. ZAP-70 protein
tyrosine kinase deficiency in an autosomal recessive form of
severe combined immunodeficiency. Science. 264:1599–1601.
9. Elder, M., D. Lin, J. Clever, A. Chan, T. Hope, A. Weiss,
and T. Parslow. 1994. Human severe combined immunode-
ficiency due to a defect in ZAP-70, a T-cell receptor-associ-
ated tyrosine kinase. Science. 264:1596–1599.
10. Gelfand, E.W., K. Weiberg, B.D. Mazer, T.A. Kadlecek, and
A. Weiss. 1995. Absence of ZAP-70 prevents signaling
through the antigen receptor on peripheral blood T cells but
not on thymocytes. J. Exp. Med. 182:1057–1065.
11. Qian, D., M.N. Mollenauer, and A. Weiss. 1996. Dominant-
negative  -associated protein 70 inhibits T cell antigen recep-
tor signaling. J. Exp. Med. 183:611–620.
12. Wange, R.L., S.N. Malek, S. Desiderio, and L.E. Samelson.
1993. The tandem SH2 domains of ZAP-70 bind to TCR  
and CD3  from activated Jurkat T cells. J. Biol. Chem. 268:
19757–19801.
13. Iwashima, M., B. Irving, N. van Oers, A. Chan, and A.
Weiss. 1994. The sequential interaction of two cytoplasmic
protein tyrosine kinases in T cell antigen receptor signaling.
Science. 263:1136–1139.
14. Hatada, M.H., X. Lu, E.R. Laird, J. Green, J.P. Morgen-
stern, M. Lous, C.S. Marr, T.B. Phillips, M.K. Ram, K.
Theriault, et al. 1995. Molecular basis for interaction of the
protein tyrosine kinase ZAP-70 with the T-cell receptor. Na-
ture. 377:32–38.
15. Isakov, N., R.L. Wange, W.H. Burgess, J.D. Watts, R. Ae-
bersold, and L.E. Samelson. 1995. ZAP-70 binding specific-
ity to T cell receptor tyrosine-based activation motifs: the
tandem SH2 domains of ZAP-70 bind distinct tyrosine-based
activation motifs with varying affinity. J. Exp. Med. 181:375–
380.
16. Chan, A.C., M. Dalton, R. Johnson, G.-H. Kong, T. Wang,
R. Thoma, and T. Kurosaki. 1995. Activation of ZAP-70 ki-
nase activity by phosphorylation of tyrosine 493 is required
for lymphocyte antigen receptor function. EMBO J. 14:
2499–2508.
17. Wange, R.L., R. Guitian, N. Isakov, J.D. Watts, R. Aeber-
sold, and L.E. Samelson. 1995. Activating and inhibitory mu-
tations in adjacent tyrosines in the kinase domain of ZAP-70.
J. Biol. Chem. 270:18730–18733.
18. Fournel, M., D. Davidson, R. Weil, and A. Veillette. 1996.
Association of tyrosine protein kinase Zap-70 with the pro-
tooncogene product p120 c-cbl in T lymphocytes. J. Exp.
Med. 183:301–306.
19. Kong, G., M. Dalton, J. Wardenburg, D. Straus, T. Kuro-
saki, and A. Chan. 1996. Distinct tyrosine phosphorylation
sites within ZAP-70 mediate activation and negative regula-
tion of antigen receptor function. Mol. Cell. Biol. 16:5026–
5035.
20. Zhao, Q., and A. Weiss. 1996. Enhancement of lymphocyte
responsiveness by a gain-of-function mutation of ZAP-70.
Mol. Cell. Biol. 16:6765–6774.
21. Lupher, M., Z. Songyang, S. Shoelson, L. Cantley, and H.
Band. 1997. The cbl phosphotyrosine-binding domain selects
a D(N/D)XpY motif and binds to the Tyr 292 negative reg-
ulatory phosphorylation site of ZAP-70. J. Biol. Chem. 272:
33140–33144.
22. Meng, W., S. Sawasdikosol, S.J. Burakoff, and M.J. Eck.
1999. Structure of the amino-terminal domain of Cbl com-
plexed to its binding site on ZAP-70 kinase. Nature. 398:84–90.
23. Rao, N., M.L.J. Lupher, S. Ota, K.A. Reedquist, B.J.
Druker, and H. Band. 2000. The linker phosphorylation site
Tyr 292 mediates the negative regulatory effect of Cbl on
ZAP-70 in T cells. J. Immunol. 164:4616–4626.
24. Joazeirro, C., S. Wing, H. Huang, J. Leverson, T. Hunter,
and Y. Liu. 1999. The tyrosine kinase negative regulator c-Cbl
as a RING-type, E2-dependent ubiquitin-protein ligase. Sci-
ence. 286:309–312.
25. Levkowitz, G., H. Waterman, S. Etternberg, M. Katz, A.
Tsygankov, I. Ahoy, S. Lavi, K. Iwai, Y. Reiss, A. Ciecha-
nover, et al. 1999. Ubiquitin ligase activity and tyrosine
phosphorylation underlie suppression of growth factor signal-
ing by c-Cbl/Sli-1. Mol. Cell. 4:1029–1040.
26. Katzav, S., M. Sutherland, G. Packham, T. Yi, and A. Weiss.
1994. The protein tyrosine kinase ZAP-70 can associate with
the SH2 domain of proto-Vav. J. Biol. Chem. 269:32579–
32585.518 ZAP-70 in T Cell Development
27. Wu, J., Q. Zhao, T. Kurosaki, and A. Weiss. 1997. The Vav
binding site (Y315) in ZAP-70 is critical for antigen recep-
tor-mediated signal transduction. J. Exp. Med. 185:1877–
1882.
28. Williams, B., B. Irvin, S. Sutor, C. Chini, Y. Yacyshyn, J.
Bubeck Wardenburg, M. Dalton, A. Chan, and R. Abraham.
1999. Phosphorylation of Tyr 319 in ZAP-70 is required for
T-cell antigen receptor phospholipase C- 1 and ras activa-
tion. EMBO J. 18:1832–1844.
29. Di Bartolo, V., D. Mege, V. Germain, M. Pelosi, E. Dufour,
F. Michel, G. Magistrelli, A. Isacchi, and O. Acuto. 1999.
Tyrosine 319, a newly identified phosphorylation site of
ZAP-70, plays a critical role in T cell antigen receptor signal-
ing. J. Biol. Chem. 274:6285–6294.
30. Pelose, M., V. Di Bartolo, V. Mounier, D. Mege, J. Pascussi,
E. Dufour, A. Blondel, and O. Acuto. 1999. Tyrosine 319 in
the Interdomain B of ZAP-70 is a binding site for the Src ho-
mology 2 domain of Lck. J. Biol. Chem. 274:14229–14237.
31. Zhao, Q., B. Williams, R. Abraham, and A. Weiss. 1999. In-
terdomain B in ZAP-70 regulates but is not required for
ZAP-70 signaling function in lymphocytes. Mol. Cell. Biol.
19:948–956.
32. Allen, J., K. Forbush, and R. Perlmutter. 1992. Functional
dissection of the lck proximal promoter. Mol. Cell. Biol. 12:
2758–2768.
33. Gong, Q., L. White, R. Johnson, M. White, I. Negishi, M.
Thomas, and A.C. Chan. 1997. Restoration of thymocyte
development and function in zap-70 /  mice by the Syk
protein tyrosine kinase. Immunity. 7:369–378.
34. Kisielow, P., H.S. Teh, H. Bluthmann, and H. von Boeh-
mer. 1988. Positive selection of antigen-specific T cells in
thymus by restricting MHC molecules. Nature. 335:730–733.
35. Kisielow, P., H. Bluthmann, U.D. Staerz, M. Steinmetz, and
H. von Boehmer. 1988. Tolerance in T-cell-receptor trans-
genic mice involves deletion of nonmature CD4 8  thy-
mocytes. Nature. 333:742–746.
36. Dower, N., S. Stang, D. Bottorff, J. Ebinu, P. Dickie, H. Os-
tergaard, and J. Stone. 2000. RasGRP is essential for mouse
thymocyte differentiation and TCR signaling. Nat. Immunol.
1:317–321.
37. Ebinu, J., S. Stang, C. Teixeira, D. Bottorff, J. Hooton, P.
Blumberg, M. Barry, R. Bleakley, H. Ostergaard, and J.
Stone. 2000. RasGRP links T-cell receptor signaling to Ras.
Blood. 95:3199–3203.
38. Magnan, A., V. Di Bartolo, A.-M. Pichonnat, C. Boyer, M.
Richelme, Y.-L. Lin, A. Roure, A. Gillet, C. Arrieumerlou,
A. Trautmann, et al. 2001. T cell development and T cell re-
sponses in mice with mutations affecting tyrosines 292 or 315
of the ZAP-70 protein tyrosine kinase. J. Exp. Med. 194:
491–505.
39. Cheng, A.M., I. Negishi, S.J. Anderson, A.C. Chan, J.
Bolen, D.Y. Loh, and T. Pawson. 1997. Arrested develop-
ment of double negative thymocytes in mice lacking both the
Syk and ZAP-70 tyrosine kinases. Proc. Natl. Acad. Sci. USA.
94:9797–9801.
40. Chu, D., N. van Oers, M. Malissen, J. Harris, M. Elder, and
A. Weiss. 1999. Pre-T cell receptor signals are responsible for
the down-regulation of Syk protein tyrosine kinase expres-
sion. J. Immunol. 163:2610–2620.
41. Appleby, M.W., J.A. Gross, M.P. Cooke, S.D. Levin, X.
Qian, and R.M. Perlmutter. 1992. Defective T cell receptor
signaling in mice lacking the thymic isoform of p59fyn. Cell.
70:751–763.